van Gils Tom, Nijeboer Petula, van Waesberghe Jan Hein Tm, Coupé Veerle Mh, Janssen Kiki, Zegers Jessy A, Nurmohamed Shaikh A, Kraal Georg, Jiskoot Sabine Ci, Bouma Gerd, Mulder Chris Jj
Celiac Center Amsterdam, Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands.
United European Gastroenterol J. 2017 Apr;5(3):374-379. doi: 10.1177/2050640616663571. Epub 2016 Aug 17.
Studies in small groups of patients indicated that splenic volume (SV) may be decreased in patients with celiac disease (CD), refractory CD (RCD) type II and enteropathy-associated T-cell lymphoma (EATL).
The objective of this article is to evaluate SV in a large cohort of uncomplicated CD, RCD II and EATL patients and healthy controls.
The retrospective cohort consisted of 77 uncomplicated CD (of whom 39 in remission), 29 RCD II, 24 EATL and 12 patients with both RCD II and EATL. The control group included 149 healthy living kidney donors. SV was determined on computed tomography.
The median SV in the uncomplicated CD group was significantly larger than in controls (202 cm (interquartile range (IQR): 154-275) versus 183 cm (IQR: 140-232), = 0.02). After correction for body surface area, age and gender, the ratio of SV in uncomplicated CD versus controls was 1.28 (95% confidence interval: 1.20-1.36; < 0.001). The median SV in RCD II patients (118 cm (IQR 83-181)) was smaller than the median SV in the control group ( < 0.001).
This study demonstrates large inter-individual variation in SV. SV is enlarged in uncomplicated CD. The small SV in RCD II may be of clinical relevance considering the immune-compromised status of these patients.
对小部分患者的研究表明,乳糜泻(CD)、II型难治性乳糜泻(RCD)和肠病相关T细胞淋巴瘤(EATL)患者的脾脏体积(SV)可能会减小。
本文旨在评估一大群无并发症的CD、RCD II和EATL患者以及健康对照者的SV。
回顾性队列研究包括77例无并发症的CD患者(其中39例处于缓解期)、29例RCD II患者、24例EATL患者以及12例同时患有RCD II和EATL的患者。对照组包括149名健康的活体肾供者。通过计算机断层扫描测定SV。
无并发症的CD组的SV中位数显著大于对照组(202 cm³(四分位间距(IQR):154 - 275)vs 183 cm³(IQR:140 - 232),P = 0.02)。在校正体表面积、年龄和性别后,无并发症的CD组与对照组的SV比值为1.28(95%置信区间:1.20 - 1.36;P < 0.001)。RCD II患者的SV中位数(118 cm³(IQR 83 - 181))小于对照组的SV中位数(P < 0.001)。
本研究表明SV存在较大的个体间差异。无并发症的CD患者的SV增大。考虑到这些患者的免疫受损状态,RCD II患者较小的SV可能具有临床意义。